On one hand, upregulation of MALAT1 was reported in lung cancer, hepatocellular carcinoma, breast cancer, and colorectal carcinoma, which has been extensively reviewed previously [23,24,25,26]. Here, MALAT1 is linked to hepatocellular carcinoma.